Safety and Immunogenicity Study of GSK Biologicals' Pneumococcal Vaccine 2830930A When Administered as a Single Dose in Healthy Toddlers Aged 12-23 Months
收藏DataCite Commons2024-11-27 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006698/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess the safety, reactogenicity and immunogenicity of the
GSK Biologicals' pneumococcal vaccine 2830930A in toddlers aged 12 to 23 months at study
entry.
提供机构：
Vivli
创建时间：
2021-02-17
